Announcements Trials
Browse Landscape

Status

Recruiting 3Not yet recruiting 2Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 11Neoplasms 9Carcinoma, Hepatocellular 5Squamous Cell Carcinoma of Head and Neck 4Melanoma 3Colorectal Neoplasms 3Recurrence 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Head and Neck Neoplasms 2Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Solid Tumor, Adult 1Small Cell Lung Carcinoma 1Sarcopenia 1Rectal Neoplasms 1Ovarian Neoplasms 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1Myositis 1Metastatic Colorectal Adenocarcinoma 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Liver Neoplasms 1Hyperthermia 1Histiocytoma, Malignant Fibrous 1Hematologic Neoplasms 1Heart Diseases 1Glioma 1Eye Diseases 1Esophageal Squamous Cell Carcinoma 1

Interventions

Fluorouracil 155Oxaliplatin 133Leucovorin 124Capecitabine 90Irinotecan 88Radiotherapy 63Bevacizumab 61Cetuximab 38Folfox protocol 25Panitumumab 21Neoadjuvant Therapy 21Surgical Procedures, Operative 19Chemotherapy, Adjuvant 15Radiation 13Floxuridine 13Erlotinib Hydrochloride 13Early Intervention, Educational 13IFL protocol 11Drug Therapy 11Proctectomy 10Magnetic Resonance Spectroscopy 10Counseling 10Surveys and Questionnaires 8Sorafenib 8Psychiatric Rehabilitation 8Gene Expression Profiling 8Radiotherapy, Intensity-Modulated 7Immunohistochemistry 7Gemcitabine 7Celecoxib 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Rectal Neoplasms × Immune Checkpoint Inhibitors × Clear all
NCT06900686 2025-03-28

Clinical Application of PD-1 Inhibitor in Colorectal Cancer for Improving Survival

Sun Yat-sen University

Completed
458 enrolled
Gastrointestinal

Parkinson Disease 4, Autosomal Dominant Lewy Body, Colonic Neoplasms, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡